ID   CCNK_HUMAN              Reviewed;         580 AA.
AC   O75909; Q59FT6; Q86U16; Q96B63; Q9NNY9;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   22-JUL-2015, entry version 150.
DE   RecName: Full=Cyclin-K;
GN   Name=CCNK; Synonyms=CPR4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, SUBUNIT, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9632813;
RA   Edwards M.C., Wong C., Elledge S.J.;
RT   "Human cyclin K, a novel RNA polymerase II-associated cyclin
RT   possessing both carboxy-terminal domain kinase and Cdk-activating
RT   kinase activity.";
RL   Mol. Cell. Biol. 18:4291-4300(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-348 (ISOFORMS 1/3).
RA   Elledge S., Gerber S., Rozet J., Perrault I., Ducroq D., Munnich A.,
RA   Kaplan J.;
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 191-580 (ISOFORM 4).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 279-580 (ISOFORM 4).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   FUNCTION, AND INTERACTION WITH CDK9.
RC   TISSUE=T-cell;
RX   PubMed=10574912; DOI=10.1074/jbc.274.49.34527;
RA   Fu T.J., Peng J., Lee G., Price D.H., Flores O.;
RT   "Cyclin K functions as a CDK9 regulatory subunit and participates in
RT   RNA polymerase II transcription.";
RL   J. Biol. Chem. 274:34527-34530(1999).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324 AND SER-340, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324 AND SER-340, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-329 AND
RP   SER-340, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=22012619; DOI=10.1101/gad.16962311;
RA   Blazek D., Kohoutek J., Bartholomeeusen K., Johansen E., Hulinkova P.,
RA   Luo Z., Cimermancic P., Ule J., Peterlin B.M.;
RT   "The Cyclin K/Cdk12 complex maintains genomic stability via regulation
RT   of expression of DNA damage response genes.";
RL   Genes Dev. 25:2158-2172(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324 AND SER-340, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 11-267.
RX   PubMed=17169370; DOI=10.1016/j.jmb.2006.11.057;
RA   Baek K., Brown R.S., Birrane G., Ladias J.A.;
RT   "Crystal structure of human cyclin K, a positive regulator of cyclin-
RT   dependent kinase 9.";
RL   J. Mol. Biol. 366:563-573(2007).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 1-267 IN COMPLEX WITH CDK12,
RP   AND INTERACTION WITH CDK12.
RX   PubMed=24662513; DOI=10.1038/ncomms4505;
RA   Boesken C.A., Farnung L., Hintermair C., Merzel Schachter M.,
RA   Vogel-Bachmayr K., Blazek D., Anand K., Fisher R.P., Eick D.,
RA   Geyer M.;
RT   "The structure and substrate specificity of human Cdk12/Cyclin K.";
RL   Nat. Commun. 5:3505-3505(2014).
CC   -!- FUNCTION: Regulatory subunit of cyclin-dependent kinases that
CC       mediates activation of target kinases. Plays a role in
CC       transcriptional regulation via its role in regulating the
CC       phosphorylation of the C-terminal domain (CTD) of the large
CC       subunit of RNA polymerase II (POLR2A).
CC       {ECO:0000269|PubMed:10574912, ECO:0000269|PubMed:22012619,
CC       ECO:0000269|PubMed:9632813}.
CC   -!- SUBUNIT: Regulatory subunit of cyclin-dependent kinases.
CC       Identified in a complex with a kinase and the RNA polymerase II
CC       holoenzyme. Interacts with POLR2A. Interacts with CDK12 and CDK13.
CC       Interacts with CDK9 according to PubMed:10574912; does not
CC       interact with CDK9 according to PubMed:22012619.
CC       {ECO:0000269|PubMed:10574912, ECO:0000269|PubMed:22012619,
CC       ECO:0000269|PubMed:24662513, ECO:0000269|PubMed:9632813}.
CC   -!- INTERACTION:
CC       Q08117:AES; NbExp=3; IntAct=EBI-739806, EBI-717810;
CC       P54253:ATXN1; NbExp=2; IntAct=EBI-739806, EBI-930964;
CC       O14503:BHLHE40; NbExp=3; IntAct=EBI-739806, EBI-711810;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-739806, EBI-741037;
CC       O14777:NDC80; NbExp=3; IntAct=EBI-739806, EBI-715849;
CC       Q93062:RBPMS; NbExp=4; IntAct=EBI-739806, EBI-740322;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22012619}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O75909-3; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75909-2; Sequence=VSP_010830, VSP_035972;
CC       Name=3;
CC         IsoId=O75909-1; Sequence=VSP_035971, VSP_035973;
CC       Name=4;
CC         IsoId=O75909-4; Sequence=VSP_035970;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Highest levels in
CC       testis. {ECO:0000269|PubMed:9632813}.
CC   -!- SIMILARITY: Belongs to the cyclin family. Cyclin C subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS SNPs;
CC       URL="http://egp.gs.washington.edu/data/ccnk/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF060515; AAD09978.1; -; mRNA.
DR   EMBL; BT006950; AAP35596.1; -; mRNA.
DR   EMBL; AF542236; AAN06829.1; -; Genomic_DNA.
DR   EMBL; AL110504; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015935; AAH15935.1; -; mRNA.
DR   EMBL; AH009612; AAF82290.1; -; Genomic_DNA.
DR   EMBL; BX247958; CAD62298.1; -; mRNA.
DR   EMBL; AB209373; BAD92610.1; -; Transcribed_RNA.
DR   CCDS; CCDS45160.1; -. [O75909-3]
DR   RefSeq; NP_001092872.1; NM_001099402.1. [O75909-3]
DR   RefSeq; XP_005268211.1; XM_005268154.3. [O75909-3]
DR   RefSeq; XP_011535577.1; XM_011537275.1. [O75909-3]
DR   UniGene; Hs.510409; -.
DR   PDB; 2I53; X-ray; 1.50 A; A=11-267.
DR   PDB; 4CXA; X-ray; 3.15 A; B/D=11-267.
DR   PDB; 4NST; X-ray; 2.20 A; B/D=1-267.
DR   PDB; 4UN0; X-ray; 3.15 A; A/B=11-267.
DR   PDBsum; 2I53; -.
DR   PDBsum; 4CXA; -.
DR   PDBsum; 4NST; -.
DR   PDBsum; 4UN0; -.
DR   ProteinModelPortal; O75909; -.
DR   SMR; O75909; 14-267.
DR   BioGrid; 114339; 32.
DR   IntAct; O75909; 20.
DR   MINT; MINT-1437641; -.
DR   STRING; 9606.ENSP00000374529; -.
DR   BindingDB; O75909; -.
DR   ChEMBL; CHEMBL3038475; -.
DR   PhosphoSite; O75909; -.
DR   BioMuta; CCNK; -.
DR   MaxQB; O75909; -.
DR   PaxDb; O75909; -.
DR   PRIDE; O75909; -.
DR   DNASU; 8812; -.
DR   Ensembl; ENST00000389879; ENSP00000374529; ENSG00000090061.
DR   GeneID; 8812; -.
DR   KEGG; hsa:8812; -.
DR   UCSC; uc001ygi.4; human. [O75909-3]
DR   CTD; 8812; -.
DR   GeneCards; GC14P099947; -.
DR   HGNC; HGNC:1596; CCNK.
DR   HPA; HPA000645; -.
DR   MIM; 603544; gene.
DR   neXtProt; NX_O75909; -.
DR   PharmGKB; PA26161; -.
DR   eggNOG; COG5333; -.
DR   GeneTree; ENSGT00760000119191; -.
DR   HOGENOM; HOG000220828; -.
DR   HOVERGEN; HBG050836; -.
DR   InParanoid; O75909; -.
DR   OMA; KIETSHP; -.
DR   OrthoDB; EOG7VQJCR; -.
DR   TreeFam; TF101010; -.
DR   SignaLink; O75909; -.
DR   ChiTaRS; CCNK; human.
DR   EvolutionaryTrace; O75909; -.
DR   GeneWiki; Cyclin_K; -.
DR   GenomeRNAi; 8812; -.
DR   NextBio; 33052; -.
DR   PRO; PR:O75909; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; O75909; -.
DR   CleanEx; HS_CCNK; -.
DR   ExpressionAtlas; O75909; baseline and differential.
DR   Genevisible; O75909; HS.
DR   GO; GO:0002944; C:cyclin K-CDK12 complex; IPI:MGI.
DR   GO; GO:0002945; C:cyclin K-CDK13 complex; IPI:MGI.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IDA:MGI.
DR   GO; GO:0019901; F:protein kinase binding; IPI:MGI.
DR   GO; GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IDA:MGI.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0044828; P:negative regulation by host of viral genome replication; IDA:CACAO.
DR   GO; GO:0071157; P:negative regulation of cell cycle arrest; IGI:MGI.
DR   GO; GO:2001165; P:positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues; IMP:CACAO.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:GOC.
DR   GO; GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   Gene3D; 1.10.472.10; -; 1.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR015429; Cyclin_C/H/T/L.
DR   InterPro; IPR006671; Cyclin_N.
DR   PANTHER; PTHR10026; PTHR10026; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 2.
DR   SUPFAM; SSF47954; SSF47954; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell division;
KW   Complete proteome; Cyclin; Mitosis; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    580       Cyclin-K.
FT                                /FTId=PRO_0000080478.
FT   COMPBIAS    312    315       Poly-Gln.
FT   MOD_RES     324    324       Phosphoserine.
FT                                {ECO:0000269|PubMed:18691976,
FT                                ECO:0000269|PubMed:19369195,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES     329    329       Phosphoserine.
FT                                {ECO:0000269|PubMed:20068231}.
FT   MOD_RES     340    340       Phosphoserine.
FT                                {ECO:0000269|PubMed:17081983,
FT                                ECO:0000269|PubMed:18691976,
FT                                ECO:0000269|PubMed:19369195,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692}.
FT   VAR_SEQ     308    354       QQPAQQQQPAQQPKKPSPQPSSPRQVKRAVVVSPKEENKAA
FT                                EPPPPK -> LILLQGWACRQPATHLLPSPLEDSLLCPRPF
FT                                PHPACLQLGGWGGQPG (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_010830.
FT   VAR_SEQ     338    338       V -> VSGLKQALGRAGFPGGGNTQV (in isoform
FT                                4). {ECO:0000303|Ref.7,
FT                                ECO:0000303|Ref.8}.
FT                                /FTId=VSP_035970.
FT   VAR_SEQ     351    357       PPPKIPK -> APSQHLW (in isoform 3).
FT                                {ECO:0000303|PubMed:9632813}.
FT                                /FTId=VSP_035971.
FT   VAR_SEQ     355    580       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_035972.
FT   VAR_SEQ     358    580       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9632813}.
FT                                /FTId=VSP_035973.
FT   CONFLICT    191    191       D -> T (in Ref. 7; BAD92610).
FT                                {ECO:0000305}.
FT   STRAND       21     23       {ECO:0000244|PDB:2I53}.
FT   HELIX        28     33       {ECO:0000244|PDB:2I53}.
FT   HELIX        35     38       {ECO:0000244|PDB:2I53}.
FT   HELIX        43     63       {ECO:0000244|PDB:2I53}.
FT   HELIX        68     81       {ECO:0000244|PDB:2I53}.
FT   TURN         82     84       {ECO:0000244|PDB:2I53}.
FT   TURN         87     89       {ECO:0000244|PDB:2I53}.
FT   HELIX        92    106       {ECO:0000244|PDB:2I53}.
FT   HELIX       113    123       {ECO:0000244|PDB:2I53}.
FT   HELIX       126    129       {ECO:0000244|PDB:2I53}.
FT   HELIX       130    132       {ECO:0000244|PDB:2I53}.
FT   HELIX       136    150       {ECO:0000244|PDB:2I53}.
FT   TURN        151    153       {ECO:0000244|PDB:2I53}.
FT   HELIX       160    169       {ECO:0000244|PDB:2I53}.
FT   HELIX       175    192       {ECO:0000244|PDB:2I53}.
FT   TURN        193    196       {ECO:0000244|PDB:2I53}.
FT   HELIX       197    199       {ECO:0000244|PDB:2I53}.
FT   HELIX       203    218       {ECO:0000244|PDB:2I53}.
FT   HELIX       222    225       {ECO:0000244|PDB:2I53}.
FT   STRAND      226    228       {ECO:0000244|PDB:2I53}.
FT   HELIX       234    237       {ECO:0000244|PDB:2I53}.
FT   STRAND      239    241       {ECO:0000244|PDB:2I53}.
FT   HELIX       244    255       {ECO:0000244|PDB:2I53}.
FT   TURN        256    258       {ECO:0000244|PDB:2I53}.
FT   STRAND      259    261       {ECO:0000244|PDB:2I53}.
SQ   SEQUENCE   580 AA;  64240 MW;  8A945E90359AD9F8 CRC64;
     MKENKENSSP SVTSANLDHT KPCWYWDKKD LAHTPSQLEG LDPATEARYR REGARFIFDV
     GTRLGLHYDT LATGIIYFHR FYMFHSFKQF PRYVTGACCL FLAGKVEETP KKCKDIIKTA
     RSLLNDVQFG QFGDDPKEEV MVLERILLQT IKFDLQVEHP YQFLLKYAKQ LKGDKNKIQK
     LVQMAWTFVN DSLCTTLSLQ WEPEIIAVAV MYLAGRLCKF EIQEWTSKPM YRRWWEQFVQ
     DVPVDVLEDI CHQILDLYSQ GKQQMPHHTP HQLQQPPSLQ PTPQVPQVQQ SQPSQSSEPS
     QPQQKDPQQP AQQQQPAQQP KKPSPQPSSP RQVKRAVVVS PKEENKAAEP PPPKIPKIET
     THPPLPPAHP PPDRKPPLAA ALGEAEPPGP VDATDLPKVQ IPPPAHPAPV HQPPPLPHRP
     PPPPPSSYMT GMSTTSSYMS GEGYQSLQSM MKTEGPSYGA LPPAYGPPAH LPYHPHVYPP
     NPPPPPVPPP PASFPPPAIP PPTPGYPPPP PTYNPNFPPP PPRLPPTHAV PPHPPPGLGL
     PPASYPPPAV PPGGQPPVPP PIPPPGMPPV GGLGRAAWMR
//
